Teriparatide

Known as: hPTH (1-34), (1-34)-Human Parathyroid Hormone, Human Parathyroid Hormone (1-34) 
A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND Osteoporosis medications increase bone-mineral density (BMD) and lower but do not eliminate fracture risk. The… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Intermittent administration of teriparatide, a drug composed of the first 34 amino acids of parathyroid hormone, has… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Animal experiments show a dramatic improvement in skeletal repair by teriparatide. We tested the hypothesis that recombinant… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced… (More)
  • figure 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Antiresorptive agents for the treatment of osteoporosis suppress bone remodeling and reestablish bone turnover at a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
UNLABELLED The relationship between early changes in biochemical markers of bone turnover and the subsequent BMD response to… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Teriparatide (recombinant human parathyroid hormone [1-34]) reduces fracture risk in postmenopausal women with… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Teriparatide (rhPTH[1-34]), a bone-forming agent for the treatment of osteoporosis, increases bone mineral density in men and… (More)
  • figure 1
  • figure 3
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Teriparatide [rhPTH(1-34)] increases bone mineral density and reduces the risk of vertebral fracture in women. We randomized 437… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
UNLABELLED Histomorphometry and microCT of 51 paired iliac crest biopsy specimens from women treated with teriparatide revealed… (More)
Is this relevant?